Professor Ronald Chung Dean of School of Continuing Education, HKBU

We are profoundly grateful for the tremendous support we have received from The Hong Kong Jockey Club Charities Trust. With the Trust’s generous donation, the School of Continuing Education of HKBU has been able to collaborate with industry partners and secondary schools to launch the CLAP-TECH Pathway Project in 2020, a project that aims to develop an alternative study pathway for students. Participating students can obtain knowledge in relation to information technology and develop diverse interests and skills required for the “new collar” jobs in Hong Kong. In a unique feature, the initiative invited over 100 industry professionals to be mentors of 460 students and, through internships, visits and hands-on learning experiences, encouraged them to start planning their career path early and develop their interests for a life-long career. As the project steps into its 4th year, our 1st cohort of students completed secondary school and a portion of them are now continuing their CLAP-TECH journey at HKBU in our new Higher Diploma in Data Science programme.

Professor Kara Chan Associate Dean of Communication (Teaching and Learning) and Professor in Communication Studies, HKBU

To cope with the new digital era, creative media is one of the fast-growing industries in Hong Kong. Under the CLAP-TECH Pathway Project, HKBU’s School of Communication, industry partners and secondary schools collaborate in a tripartite partnership to roll out applied learning courses titled “Multimedia Storytelling” for senior secondary schools. The course provides students with a systematic comprehension and skills of content creation in various platforms. Co-curricular activities also equip students with the practical skills that are required in the creative industry. Students can learn through practical and extensive experiences with the inclusion of career planning elements. They can apply what they have learnt to different multimedia contexts such as public relations, advertising, sales and marketing, entertainment production and livestreaming. Participating students and teachers also commended the project for providing knowledge of the industry while at the same time teaching problem-solving plus analytical and communication skills that they can apply in different kinds of future jobs. 

Professor Ken K.L. Yung Director of Golden Meditech Centre for NeuroRegeneration Sciences, and Professor of Department of Biology of HKBU

With populations around the world ageing, it is predicted that the number of patients suffering from neurodegenerative diseases such as Alzheimer’s and Parkinson’s will rise dramatically, posing an increasingly serious threat to public health. I would like to express my heartfelt thanks to Mr. Kam Yuen, Founder of Golden Meditech Holdings Limited, for his generous support for the establishment of the Golden Meditech Centre for NeuroRegeneration Sciences. The Centre will conduct in-depth research related to autologous neural stem cell therapy and other cell therapies that can potentially treat neurodegenerative and other diseases that are presently incurable.

Professor Jonathan Wong, BBS, MH, JP Director of Hong Kong Organic Resource Centre of HKBU

HKBU has always been committed to promoting environmental protection.  With donors’ support, the Hong Kong Organic Resource Centre organises an array of green projects every year to increase the awareness of the general public about the importance of environmental protection and organic lifestyle in order to foster a sustainable environment for the benefit of future generations.

Professor Li Min Director of Teaching and Research Division of School of Chinese Medicine of HKBU

The Mr. and Mrs. Ko Chi Ming Centre for Parkinson’s Disease Research, in close collaboration with first-class higher education institutions and research institutes on the Mainland and overseas, will explore and analyse the etiology and pathogenesis of Parkinson’s disease (PD) and discover new drugs in Chinese medicine for the prevention and treatment of the disease, benefiting all PD patients in Hong Kong and throughout the world.